4D Molecular Therapeutics, Inc. Common Stock

FDMTNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
15.56 USD
↘ 0.16 (1.02%)AT CLOSE (11:59 AM EDT)
15.75
↗ 0.18 (1.19%)
POST MARKET (AS OF 07:36 PM EDT)
Post Market
AS OF 07:36 PM EDT
15.75
↗ 0.18 (1.19%)
🔴Market: CLOSED

Shares of 4D Molecular Therapeutics, Inc. Common Stock (FDMT) are trading at $15.56. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place FDMT at a fair price relative to peers.

Technical & fundamental data as of Aug 26, 2026.

Open?$15.50
High?$15.67
Low?$15.04
Prev. Close?$15.72
Volume?717.9K
Avg. Volume?907.1K
VWAP?$15.42
Rel. Volume?0.79x
Bid / Ask
Bid?$15.56 × 100
Ask?$16.00 × 200
Spread?$0.44
Midpoint?$15.78
Valuation & Ratios
Market Cap?859.6M
Shares Out?55.2M
Float?44.5M
Float %?85.2%
P/E Ratio?N/A
P/B Ratio?1.90
EPS?-$2.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Clinical-Stage Platforms
Employees
196
Market Cap
868.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.4dmoleculartherapeutics.com
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
45
Short Sent.?
30
Piotroski F-Score?1/9Weak
Altman Z-Score?6.17Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?27.60%Squeeze Risk
Short Interest?12.3M
Days to Cover?22.3
Free Float44.5M
Avg Daily Volume550.7K
Settlement Date2026-08-14
Financial Health
Current Ratio?9.34Strong
Quick Ratio?9.34Strong
Cash Ratio?1.67Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
77
1.90CHEAP▾
P/S?
Peers
100
S&P
9
9.74HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.5CHEAP▾
EV/Sales?
Peers
100
S&P
14
8.92HIGH▾
Returns & Efficiency
ROE?
S&P
5
-35.6%WEAK▾
ROA?
S&P
3
-31.4%WEAK▾
Cash Flow & Enterprise
FCF?$-129544000
Enterprise Value?$787.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist